Women with FGS had a significantly higher proportion of CD3−CD56−CD14+ cells than FGS- women in blood samples (median 11.5% (IQR 4.7–19.9) vs. 2.2% (IQR 0.9–5.7) respectively, p = 0.042; Figure 4A), whereas there was no significant difference for CCR5 expression on CD14+ cells (p = 0.89; data not shown). The gene discussed is CCR5; the disease is focal segmental glomerulosclerosis.